Man­u­fac­tur­ing roundup: Catal­ent caps off man­u­fac­tur­ing site in Bel­gium; Eu­roAPI restarts pro­duc­tion in Hun­gary

Catal­ent is open­ing the doors to a new plas­mid DNA man­u­fac­tur­ing site at one of its core sites in Eu­rope.

The new 12,000-square-foot plas­mid man­u­fac­tur­ing site is lo­cat­ed in its cell ther­a­py cen­ter in Gos­selies, Bel­gium, and has mul­ti­ple clean­rooms meant to pro­duce cGMP-grade plas­mid DNA for clin­i­cal and com­mer­cial pur­pos­es. The site will al­so see Catal­ent pro­duc­ing plas­mids that are in­tend­ed to be used by cell and gene com­pa­nies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER